ClinicalTrials.Veeva

Menu

AQP-1 Polymorphism on Fluid Status in Hemodialysis Patients

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Not yet enrolling

Conditions

End Stage Renal Disease on Dialysis

Treatments

Other: observational study, no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05275387
KY2021-149-B

Details and patient eligibility

About

It is a cross sectional observational study. It is to investigate whether AQP-1 polymorphism has any impact on fluid status in hemodialysis patients. The long term stable HD patients in the current center will be enrolled to the study after informed consent. Blood samples will be collected for gene-typing. Fluid status including blood pressure, weekly UF and intra-dialysis body weight change will be collected through their clinical records.

Enrollment

250 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 18-70
  • ESRD
  • maintained HD
  • no target weight change during the last week of entering the study and achieve target weight at the end of HD section
  • informed consented

Exclusion criteria

  • expected survival time less than 3 months

Trial contacts and locations

1

Loading...

Central trial contact

Zanzhe Yu, PhD; Qi Lu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems